Neurodegeneration
Experimental therapeutics of neurodegenerative disorders: unmet needs.
Science. 1998 Nov 6;282(5391):1072-4
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
.N Engl J Med 1997 Apr 24;336(17):1216-22
DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism
.Ann Neurol 1998 Sep;44(3 Suppl 1):S160-6
Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group
. Ann Neurol. 1998 Mar;43(3):318-25.
Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. The Parkinson Study Group
. N Engl J Med. 1993 Jan 21;328(3):176-83.
An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.
Brain 1996 Apr;119 ( Pt 2):585-91
Assessment of coenzyme Q10 tolerability in Huntington's disease.
Mov Disord 1996 May;11(3):321-3
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
. Ann Neurol 1997 Feb;41(2):160-5
A controlled trial of remacemide hydrochloride in Huntington's disease
. Mov Disord 1996 May;11(3):273-7
Current pharmacotherapies for Alzheimer's disease.
Geriatrics 1998 Sep;53 Suppl 1:S31-4
Human Adults Do Grow New Neurons
Neurogenesis in the adult human hippocampus.
Nat Med 1998 Nov;4(11):1313-7. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH
Copyright © 2006 MDinteractive, LLC. All Rights Reserved
Terms & Conditions